Genmab A/S Stock
€286.00
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Genmab
sharewise wants to provide you with the best news and tools for Genmab, so we directly link to the best financial data sources.
Financials
News
Why Genmab Stock Popped on Friday
Before the market open on the last trading day of the week, two analysts tracking Genmab (NASDAQ: GMAB) stock felt compelled to raise their price targets on the biotech. This double-barreled blast
Why Genmab Stock Was Marching Higher Today
One day after announcing a sizable acquisition, Denmark-based biotech Genmab (NASDAQ: GMAB) was doing well on the stock exchange Tuesday. A pair of analysts weighed in with bullish new takes on the


